Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA. TNF-alpha(-/-) mice developed 5-10% the number of tumors developed by wild-type mice during initiation/promotion and 25% of those in wild-type mice after repeated carcinogen treatment. TNF-alpha could influence tumor and stromal cells during tumor development. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. These were diminished in TNF-alpha(-/-) mice. TNF-alpha was extensively induced in the epidermis, but not the dermis, in TPA-treated wild-type skin, indicating that dermal inflammation is controlled by keratinocyte TNF-alpha production. Deletion of a TNF-alpha inducible chemokine also conferred some resistance to skin tumor development. TNF-alpha has little influence on later stages of carcinogenesis, as tumors in wild-type and TNF-alpha(-/-) mice had similar rates of malignant progression. These data provide evidence that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-alpha is important to the early stages of tumor promotion. Strategies that neutralize TNF-alpha production may be useful in cancer treatment an…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCP1 is a critical chemoattractant responsible for the recruitment of macrophages into tumor and for angiogenesis in breast cancer [131, 132], and may contribute to indirect crosstalk between MSC and cancer cells via recruitment of tumor-resident macrophages.”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [132]
Citations
Cites
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,626
Correa, P. (1992) · PubMed · Cited by 3,216
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationLu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Self-citation
Cited by
Items 701–800 of 838
Carcinomes basocellulaires multiples après traitement d’un psoriasis par étanercept
Maire, C., Delesalle, F., Carpentier, O., Lequint, P., Delaporte, E., & Thomas, P. (2009) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2008.10.036 · Cited by 4
Potencial anti-apoptótico de p38 en cáncer de próstata
Belinchón, M. R., de Bethencourt, F. R., llanio, I. G.-T., Laiz, B. F., sáez, C. F., tresguerres, P. A., González-garcía, J., Martín, R. V. S., Paniagua, R., & Royuela, M. (2005) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(05)73339-8 · Cited by 4
Tumor Necrosis Factor–α as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome
Jatoi, A., Sideras, K., & Nguyen, P. (2004) · Supportive Cancer Therapy · doi:10.3816/sct.2004.n.016 · Cited by 5
Sparsa, A. (2005) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(05)79505-3 · Cited by 4
Villarrubia, V. G., Tarazona, R., Solana, R., & González, S. (2001) · Piel · doi:10.1016/s0213-9251(01)72511-7 · Cited by 4
Cellular and Molecular Mechanisms of Tumor Promotion
Sadler, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64273-3 · Cited by 4
Murthy, K. S., & Kiran, B. R. (2012) · International Research Journal of Pharmacy · Cited by 7
Fernández‐Piqueras, J., & Hernández, J. S. (2002) · Revista de Oncología · doi:10.1007/bf02713040 · Cited by 3
Cancer Pathogenesis and DNA Sensing
Shen, Y. J., Lam, A. R., Ho, S. W. S., Koo, C. X., Bert, N. L., & Gasser, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00009-5 · Cited by 5
Ning, J., Huang, S., Wu, J. L., Meng, L., & Shou, C. (2003) · 中国科学通报:英文版 · doi:10.1007/bf03325650 · Cited by 3
Strategies in Skin Cancer Chemoprevention
Stratton, M. S., Stratton, S. P., Ranger‐Moore, J., Einspahr, J. G., Bowden, G. T., & Alberts, D. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59259-768-0_30 · Cited by 3
Dermatological Side Effects of Anti-tumor Necrosis Factor Alpha Therapy
Moon, S. H., & Ko, J. Y. (2014) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2014.21.1.9 · Cited by 3
Sharma, M., Mohapatra, J., Argade, A., Deshpande, S. S., Shah, G. B., Chatterjee, A., & Jain, M. R. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.931421 · Cited by 3
Th-17 cells as novel participants in immunity to breast cancer
Jovanović, I., Radosavljevic, G. D., Pavlovic, S. M., Zdravkovic, N. S., Martinova, K., Knežević, M., Živić, D., Lukić, M. L., & Arsenijević, N. (2010) · Serbian Journal of Experimental and Clinical Research · Cited by 8
Dissecting neutrophil complexity in cancer
Ponzetta, A., Mantovani, A., & Jaillon, S. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170062 · Cited by 3
Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma
Wang, X., Chen, S., Chen, G., Zhou, H., Gan, T., Zeng, J., & Li, Z.-Y. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/6614331 · Cited by 3
Brodt, P. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_10 · Cited by 4
Smith, K. J., & Skelton, H. G. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)00812-0 · Cited by 3
Tsujimoto, M., Fujita, T., Furukawa, T., Arima, Y., Nibu, K., & Nishigori, C. (2025) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2025.01.003 · Cited by 2
Fisher, B. A., Rowe, A. L., Hodson, C., Wilkhu, M., Williams, E. L., Turner, E., Allard, A., Blake, T., Bombardieri, M., Cope, A. P., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-116847 · Cited by 3
Chandran, K., Guo, C., Pacey, S., Villacampa, G., Matthews, R., Prout, T., Fernandes, J., Turner, A., Parmar, M., Riisnaes, R., et al. (2026) · Investigational New Drugs · doi:10.1007/s10637-026-01619-x · Cited by 2
Inoue, Y., Shimizu, A., Suto, M., Kishi, C., Takahashi, A., Yasuda, M., Iijima, M., Arakawa, H., & Ishikawa, O. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14482 · Cited by 2
Simpronio, M. D. R., Machado, A. R. T., dos Santos, P. W. D. S., Ribeiro, D. L., Antunes, L. M. G., & Aissa, A. F. (2025) · ACS Omega · doi:10.1021/acsomega.5c00839 · Cited by 3
Oral Infection, Carcinogenesis and Cancer
Meurman, J. H., & Martínez, A. B. (2015) · Springer eBooks · doi:10.1007/978-3-319-20669-1_11 · Cited by 1
Serum from morbidly obese patients affects melanoma cell behavior in vitro
Mocellin, D., Bratti, L. D. O. S., Silva, A. H., Assunção, L. S., Kretzer, I. F., & Filippin-Monteiro, F. B. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-979020201000x42e19375 · Cited by 2
Denning, M. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_16 · Cited by 2
Tumor Antigens Revealed by Exome Seqeuncing Drive Editing of Tumor Immunogenicity
Vesely, M. D. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7c8278n · Cited by 1
Increased DNA damage in hematopoietic cells of mice with graft-versus-host disease
Kusunoki, Y., Hamasaki, K., Koyama, K., Imai, K., Hayashi, T., Martin, P. J., & Nakachi, K. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.05.002 · Cited by 2
The Inflammatory Tissue Microenvironment and the Early Stages of Malignancy
Balkwill, F. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6694-0_2 · Cited by 2
Self-citationMolecular mechanisms of inflammation – a central role for cytosolic phospholipase A2
Sommerfelt, R. M. (2014) · NORA - Norwegian Open Research Archives · Cited by 2
Niwa, K., Lian, Z., Tagami, K., Gao, J., & Tamaya, T. (2003) · Springer eBooks · doi:10.1007/978-4-431-53981-0_12 · Cited by 1
The role of cytokines in ovarian cancer drug resistance
Wang, L., Zang, Y., Dejenie, R., Bing, J., Dong, S., Zhang, Y., Zhu, Y., & Li, J. (2025) · International Journal of Cancer · doi:10.1002/ijc.70099 · Cited by 6
Dyer, A., Dudley, R., Ahuja, S., Alsinet, C., Poudel, P., Bowyer, G., Sahota, K., Songvilay, S., Jones, D. C., Glover, M. S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30224-w · Cited by 1
Abdulhameed, A. R. A. Y. A. H. M. A. A. (2012) · THE EGYPTIAN JOURNAL OF EXPERIMENTAL BIOLOGY (Botany) · Cited by 1
Using mice to unveil the genetics of cancer resistance
van der Weyden, L., & Adams, D. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.003 · Cited by 3
Stuhr, L. E. B., Moen, I. N., Nedrebø, T., Salnikov, A. V., Wiig, H., Rubin, K., & Reed, R. K. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510801971703 · Cited by 1
Cooper, M. A., & Caligiuri, M. A. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50057-0 · Cited by 3
Inflammatory Mediators in Tumorigenesis and Metastasis
Dupaul-Chicoine, J., & Saleh, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3685-0_9 · Cited by 1
Physiologic Roles of Members of the TNF and TNF Receptor Families as Revealed by Knockout Models
Nedospasov, S. A., Grivennikov, S. I., & Kuprash, D. V. (2003) · doi:10.1007/978-1-59259-405-4_25 · Cited by 3
Cytokines and Chemokines in Inflammation and Cancer
Hagemann, T., & Lawrence, T. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.021 · Cited by 2
Pro-Inflammatory Cytokines (TNF-α and IL-1) in Nigerian Women with Breast Cancer
Felix, C. E., Iyare, F., & Chinedum, C. F. (2018) · Open Journal of Immunology · doi:10.4236/oji.2018.82002 · Cited by 3
Powers, A. A., Eisenberg, S. H., Jones, K. E., Stabile, L. P., Lotze, M. T., Dhupar, R., & Soloff, A. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00084-0 · Cited by 2
Xu, X. X., Pei, M., Kim, K., XI, H., Lee, S. G., Chung, K. Y., Roh, M. R., & Jin, Z. (2023) · In Vivo · doi:10.21873/invivo.13243 · Cited by 1
Identification of TNFRSF1A as a novel regulator of carfilzomib resistance in multiple myeloma
Zhao, J., YANG, X., ZHANG, H., & GU, X. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.030770 · Cited by 1
The Role of Tumour-Associated Macrophages in Malignant Invasion
Binder, C. R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_3 · Cited by 1
Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance
Katz, J. B., Muller, A. J., Metz, R. A., & Prendergast, G. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0170-5_15 · Cited by 1
Jefcoate, C. R. E., & Larsen, M. C. (2008) · Springer eBooks · doi:10.1007/978-0-387-77300-1_14 · Cited by 1
The role of protein phosphatase 2A in inflammation and cancer
Enjoji, S., & Ohama, T. (2017) · Folia Pharmacologica Japonica · doi:10.1254/fpj.149.208 · Cited by 1
NF-κB in Oncogenesis and As a Target for Cancer Therapy
Baldwin, A. S. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_18 · Cited by 1
Denley, S. M. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Vardanyan, M., Parkin, E., & Rilo, H. (2010) · Wiley eBooks · doi:10.1002/9781444355628.ch26 · Cited by 1
Haviv, I. (2005) · Defense Technical Information Center (DTIC) · Cited by 1
Photocarcinogenesis and Inflammation
Nishigori, C. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch19 · Cited by 2
The Links between Inflammation and Cancer
Balkwill, F. R., Charles, K. A., & Mantovani, A. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap220 · Cited by 1
Self-citationFromm, P. D. (2010) · ResearchOnline - JCU (James Cook University) · doi:10.25903/jctq-es32 · Cited by 1
Andrews, D. M., & Smyth, M. J. (2008) · Nature Immunology · doi:10.1038/ni0208-119 · Cited by 1
Expression Profiling of Ovarian Cancer: markers and targets for therapy
Helleman, J. (2006) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Commentary on “Role of phototherapy in the era of biologics”
Botsalı, A. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.08.128 · Cited by 1
Utilizing Mouse Models of Human Cancer for Assessing Immune Modulation of Cancer Development
de Visser, K. E., & Coussens, L. M. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_21
Complex Interactions Between Osteosarcoma Cells and Fibroblasts
David, M. S. (2011) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Biologics bei entzündlichen Krankheiten der Haut: Wirkungsmechanismen — Möglichkeiten — Risiken
Röcken, M., & Weigert, C. (2007) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-540-30515-6_8
Nie, S. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/sx5x-sq07
Potential Mechanisms Linking Oxidized LDL to Susceptibility to Cancer
Khaidakov, M., & Mehta, J. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5857-9_19
NF-kappaB in skin immune homeostasis and cancer development
Ulvmar, M. H. (2009) · Figshare
The Interplay of Cancer and Biology
Holder, J. W. (2010) · Wiley eBooks · doi:10.1002/9780470622728.ch5
Jans, J. J. M. (2003) · RePub (Erasmus University Rotterdam)
Lymphovascular invasion in melanoma and breast cancer
Safuan, S. (2012) · Nottingham ePrints (University of Nottingham) · Cited by 1
Shimizu, T. (2011) · InTech eBooks · doi:10.5772/25496
Matrix metalloproteinases as biomarkers in premalignant and malignant tumors of the human skin
Kuivanen, T. (2008) · Työväentutkimus Vuosikirja
Roles for the Stress-Responsive Kinases ASK1 and ASK2 in Tumorigenesis
Kamiyama, M., Sato, T. K., Takeda, K., & Ichijo, H. (2012) · Springer eBooks · doi:10.1007/978-4-431-54038-0_14
The role of epidermal growth factor receptor in inflammation and tumorgenesis
Smolle, V. (2012) · University of Vienna · doi:10.25365/thesis.19770
Cytokines as Mediators of Disease
Balkwill, F. R. (2003) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0002145
Self-citationProtein Kinase C and the Development of Squamous Cell Carcinoma
Denning, M. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7203-3_8
Cellular Cancer Processes and Their Molecular Targets for Nutritional Preemption of Cancer
Davis, C. D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-627-6_3 · Cited by 2
Massoumi, R., & Fässler, R. (2007) · International Congress Series · doi:10.1016/j.ics.2006.11.030
EVIDENCE FOR THE EXISTENCE OF CANCER IMMUNOSURVEILLANCE
Smyth, M. J., & Hayakawa, Y. (2004) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.12.9
The Pro-inflammatory Milieu and Its Role in Malignant Epithelial Initiation
Yagui‐Beltrán, A., Tang, Q., & Jablons, D. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_20
Sun-Sensitizing Effects of PKCε Shine on Multiple Mouse Strains
Denning, M. F. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.354
Mburu, Y. K. (2011) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Barcellos‐Hoff, M. H., Adams, C., Balmain, A., Costes, S. V., Demaria, S., Illa-Bochaca, I., Mao, J. H., Ouyang, H., Sebastiano, C., & TANG, J. C. Y. (2013)
A study on crosstalk between lung carcinoma and immune cells
Mushtaq, Q. D. (2012) · Shodhganga
Effects of the new Histone Deacetylase Inhibitor PXD101 in Bladder Cancer
Kaimakliotis, H. Z. (2007)
The role of inflammatory cytokine TNF-α and microenvironment in mouse gastric tumorigenesis
Oshima, H. (2014) · Folia Pharmacologica Japonica · doi:10.1254/fpj.143.279
Growth Factors in Glial Tumors
Guha, A., & Omahen, D. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00103-9
Tumor Necrosis Factor Inhibitors in Cancer-Associated Weight Loss Syndrome
Jatoi, A., & Patiyil, S. (2005) · CRC Press eBooks · doi:10.1201/9780849333798.ch26
Regulating the Master Regulator NF-_B: From Natural Strategies to Rationally Designed Superdrugs
Tergaonkar, V., Verma, I. M., & Withoff, S. (2006) · CRC Press eBooks · doi:10.1201/9781420004274.ch10
Novel Mediators for Chronic Inflammation and Oncogenic Transformation: Tumor Necrosis Factor (TNF)-α
Mukaida, N., & Popivanova, B. K. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343602_0012
Mutagenicity and Tumorigenicity of Diesel Exhausts of High-and Low-Sulfur Fuels
Iwai, K., Udagawa, T., Mizuno, S., Kawabata, Y., Sugawara, I., Goto, S., Seto, H., & Adachi, S. (2002) · Journal of Japan Society for Atmospheric Environment / Taiki Kankyo Gakkaishi · doi:10.11298/taiki1995.37.3_216
Mechanisms of Colorectal Cancer Pathogenesis: Role of Hypoxia
Thairu, N. (2013) · doi:10.25560/14361
AVALIAÇÃO IN VITRO DO POTENCIAL BIOLÓGICO DE MYRCIARIA PLINIOIDES (D. LEGRAND) EM CÉLULAS TUMORAIS
Leipelt, J. (2016) · Americanae (AECID Library) · Cited by 1
Vered, M., Buchner, A., Dayan, D., Asociado, P., & Goldschleger, G. (2003)
Hasan, A. (2015) · Journal of Babylon University · Cited by 1
Piva, M. R., & de Souza, L. B. (2009)
Corbin, M. E. (2006) · Louisiana State University · doi:10.31390/gradschool_theses.2297
Zoubi, M. S. A., Chipitsyna, G. I., Sarosiek, K., Kang, C. Y., Yeo, C. J., & Arafat, H. A. (2013) · Gastroenterology · doi:10.1016/s0016-5085(13)63978-5
Metadata
- Authors
- Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., & Balkwill, F.
- Affiliations
- Hammersmith Hospital (GB)
- Harvard University (US)
- Pasteur Hellenic Institute (GR)
- Corresponding author
- Balkwill, Frances
- ORCID
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 828-831
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1585093254
- Cited by
- 839
- References
- 21
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 20 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 18 · 2018: 16 · 2017: 19 · 2016: 37 · 2015: 32 · 2014: 46 · 2013: 44 · 2012: 41
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, skin carcinogenesis, TNF-alpha knockout mice, tumor promotion, 7,12-dimethylbenz(a)anthracene, tissue plasminogen activator, keratinocyte hyperproliferation, skin inflammation, chemokines, malignant progression, chronic inflammation and cancer, cancer prevention
- MeSH terms
- Animals, Crosses, Genetic, Female, Immunity, Innate, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred Strains, Neoplasm Invasiveness, Neoplasm Staging, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, Tumor Necrosis Factor-alpha, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.